We Value Sample Clauses

We Value. 2.2.3.1 Our People We are passionate, committed, empowered and accountable and we recognise the contribution of others.
Sample 1Sample 2
AutoNDA by SimpleDocs
We Value. ● An atmosphere of open inquiry tempered with a sense of order and consideration for others. ● The appreciation of diversity, equity, inclusion, and justice, and the opportunity to learn from the multitude of cultural backgrounds represented at international schools like AISCT. Please visit our DEIJ webpage for more information. ● We recognize the individual nature of each student and value a community in which these individuals can learn together harmoniously. ● The opportunity to stimulate the love of learning which, we believe, is inherent in every child. ● Creative and inventive thinking and the ability to approach problems from different angles. ● The opportunity to learn about South Africa, our host country, and the importance of our South African teachers and staff, who serve as our most important link to this country. ● The human relationships that constitute our community and xxxxxx learning: relationships between teachers and students, between students, between teachers and parents, and between parents and their children. ● Parents’ ideas, involvement, and contributions to the life of the school. ● The development of character and integrity in each of our students.
Sample 1
We Value.  Respect for individuals and culture  Working together and supporting each other  Involving and engaging others  Ownership, transparency and accountability  Fair and ethical decisions  Improvement focus Primary Objectives of role: Provides executive and clinical leadership to Next Step Drug and Alcohol Services consistent with the Mental Health Commission’s vision, values, strategic directions and operational plans. Ensures the effective clinical management of Next Step’s services and workforce. Leads innovation and change and provides specialist medical advice on the development and delivery of services for people with alcohol and other drug related problems. Supports the development and implementation of sound clinical governance and risk management processes. Overseas Next Step’s medical education and clinical research activities. Provides clinical supervision to senior clinicians of the Next Step Service. In undertaking the role of this position, the occupant will need to recognise that there is a commitment to focussing on the needs of the individual, their families, carers or advocates working in partnership for better mental health outcomes. General Responsibilities Clinical Leadership and Governance  Provides executive and clinical leadership to Next Step Drug and Alcohol Services consistent with the Mental Health Commission’s mission, values, strategic directions and operational plans.  Leads innovation and change within the clinical services of Next Step.  Provides specialist medical advice on the development and delivery of services for people with alcohol and other drug related problems.  Oversees the development and implementation of relevant evidence based policies, procedures and clinical guidelines for the treatment of alcohol and other drug dependence.  Supports the development and implementation of sound clinical governance including, risk management, credentialing, professional development and complaints management.  Leads changes to clinical processes and practices related to the results of clinical audits, clinical incidents, complaints and other clinical safety and quality activities.  Directs the recruitment, selection, deployment, orientation, performance management and development of the medical staff.  Provides advice on medical agreements and awards, contracts and arrangements for medical staff and partnering arrangements with other health services.  Ensures the appropriate management of medico-legal matters at Nex...
Sample 1
We Value 
Sample 1

Related to We Value

  • Fair Market Value Fair Market Value of a share of Common Stock as of a particular date (the "Determination Date") shall mean:

  • Value The value of the Mortgaged Property at the time of origination of the related Mortgage Loan, such value being the lesser of (i) the value of such property set forth in an appraisal accepted by the applicable originator of the Mortgage Loan or (ii) the sales price of such property at the time of origination.

  • Appraised Value If an Objecting Party objects in writing to the Initial Valuation within ten (10) days after its receipt of the Valuation Notice, the Objecting Party, within fourteen (14) days from the date of such written objection, shall engage an Independent Appraiser (the “First Appraiser”) to determine within thirty (30) days of such engagement the Fair Market Value of the Partnership Interests (the “First Appraised Value”). The cost of the First Appraiser shall be borne by the Objecting Party. If the First Appraised Value is at least eighty percent (80%) of the Initial Value and less than or equal to one hundred twenty percent (120%) of the Initial Value, then the Purchase Price shall be the average of the Initial Value and the First Appraised Value. If the First Appraised Value is less than eighty percent (80%) of the Initial Value or more than one hundred twenty percent (120%) of the Initial Value, then the Partnership and the Objecting Party shall, within fourteen (14) days from the date of the First Appraised Value, mutually agree on and engage a second Independent Appraiser (the “Final Appraiser”). The cost of the Final Appraiser shall be borne equally by the Partnership and the Objecting Party. The Final Appraiser shall determine within thirty (30) days after its engagement the Fair Market Value of the Partnership Interests, but if such determination is less than the lesser of the Initial Value and the First Appraised Value then the lesser of the Initial Value and the First Appraised value shall be the value or if such determination is greater than the greater of the Initial Value and the First Appraised Value then the greater of the Initial Value and the First Appraised Value shall be the value (the “Final Valuation”). The Purchase Price shall be equal to the Final Valuation and shall be final and binding upon the parties to this Agreement for purposes of the subject transaction.

  • per Share The Fund is advised that the Underwriters intend (i) to make a public offering of their respective portions of the Firm Shares as soon after the effective date of the Registration Statement as is advisable and (ii) initially to offer the Firm Shares upon the terms set forth in the Prospectus. The Underwriters may from time to time increase or decrease the public offering price after the initial public offering to such extent as they may determine. In addition, the Fund hereby grants to the several Underwriters the option to purchase, and upon the basis of the warranties and representations and subject to the terms and conditions herein set forth, the Underwriters shall have the right to purchase, severally and not jointly, from the Fund, ratably in accordance with the number of Firm Shares to be purchased by each of them, all or a portion of the Additional Shares as may be necessary to cover over-allotments made in connection with the offering of the Firm Shares, at the same purchase price per Share to be paid by the Underwriters to the Fund for the Firm Shares. This option may be exercised by the Representatives on behalf of the several Underwriters at any time and from time to time on or before the forty-fifth day following the date hereof, by written notice to the Fund. Such notice shall set forth the aggregate number of Additional Shares as to which the option is being exercised, and the date and time when the Additional Shares are to be delivered (such date and time being herein referred to as the "Additional Time of Purchase"); provided, however, that the Additional Time of Purchase shall not be earlier than the Time of Purchase (as defined below) nor earlier than the second business day after the date on which the option shall have been exercised. The number of Additional Shares to be sold to each Underwriter shall be the number which bears the same proportion to the aggregate number of Additional Shares being purchased as the number of Firm Shares set forth opposite the name of such Underwriter on Schedule A hereto bears to the total number of Firm Shares (subject, in each case, to such adjustment as the Representatives may determine to eliminate fractional shares).

  • Determination of Fair Market Value For purposes of this Section 10.2, “fair market value” of a share of Common Stock as of a particular date (the “Determination Date”) shall mean:

Time is Money Join Law Insider Premium to draft better contracts faster.